GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing

Liping Sun; Hao Jin; Hui Li

doi:10.18632/oncotarget.8753

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing

Liping Sun, Hao Jin and Hui Li _

PDF | HTML | How to cite

Oncotarget. 2016; 7:42826-42836. https://doi.org/10.18632/oncotarget.8753

Metrics: PDF 3712 views | HTML 5215 views | ?

Abstract

Liping Sun1,3,4,*, Hao Jin1,3,4,* and Hui Li2,3,4

1 Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

2 Department of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

3 Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China

4 National Clinical Research Center of Cancer, Tianjin, China

* These authors have contributed equally to this work

Correspondence to:

Hui Li, email:

Keywords: regulatory T cells, glycoprotein A repetitions predominant, transforming growth factor β

Received: January 24, 2016 Accepted: April 04, 2016 Published: April 15, 2016

Abstract

There are many molecules that define regulatory T cells (Tregs) phenotypically and functionally. Glycoprotein A repetitions predominant (GARP) is a transmembrane protein containing leucine rich repeats. Recently, GARP is found to express highly on the surface of activated Tregs. The combination of GARP and other surface molecules isolates Tregs with higher purity. Besides, GARP is a cell surface molecule of Tregs that maintains their regulatory function and homeosatsis. GARP has also been proved to promote the activation and secretion of transforming growth factor β (TGF-β). Moreover, its potential value in cancer immunotherapy is also discussed in this work.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8753

Publication Alerts

Reviews:

GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing

Abstract